Vaxxinity
Mark is their Chief of Staff at Vaxxinity after joining from United Neuroscience where he’s worked since 2017. Previously Mark spent 7 years in biopharmaceutical consulting at Simon-Kucher and CBPartners. Mark’s clients have included many top 20 life sciences companies, as well as biotech startups and healthcare-focused financial institutions. His work spans therapeutic areas and has supported some of the world’s top selling drugs. Mark holds a bioengineering MSE from Penn, and a BS magna cum laude in bioengineering and business management from Binghamton University.
This person is not in any offices
Vaxxinity
1 followers
Vaxxinity is a biotechnology company that enables the innovation of synthetic peptide vaccines to prevent or treat infectious diseases.